Answer
Pazenir (paclitaxel albumin) monotherapy is indicated for adults with metastatic breast cancer who have failed first-line treatment for metastatic disease and for whom standard anthracycline-containing therapy is not indicated.
Sources for this answer
- Paclitaxel (Pazenir) 5 mg/ml Powder for Dispersion for InfusionTeva UK Limited · emc · SmPC §4.1 Therapeutic Indications · Version 6Document updated
Sources checked